Report cover image

Japan Hospital Drug Waste Management Market - 2024-2033

Published Feb 23, 2026
Length 181 Pages
SKU # DTAM21122382

Description

Japan Hospital Drug Waste Management Market Overview:
The Japan Hospital Drug Waste Management Market was valued at US$ 243.6 Million in 2024 and is anticipated to reach US$ 570.7 Million by 2033, at a CAGR of 0.098 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Japan Hospital Drug Waste Management Market.

This report delivers a comprehensive overview of the Japan Hospital Drug Waste Management Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Japan Hospital Drug Waste Management Market. The Japan Hospital Drug Waste Management Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

Japan Hospital Drug Waste Management Market Scope:
By Type of Waste
• General Medical Waste
• Infectious Medical Waste
• Hazardous Medical Waste
• Radioactive Medical Waste
• Controlled Substance Waste
• Expired Pharmaceutical Waste
• Others

By Treatment Method
• Incineration
• Autoclaving
• Chemical Treatment
• Microwave Treatment
• Encapsulation
• Others

By Waste Source Type
• Expired Inventory Waste
• Partially Used Drug Waste
• Prescription Change Waste
• Cold-Chain Spoilage Waste
• Packaging & Handling Waste
• Compounding & Preparation Waste
• Others

By Drug Value Category
• Ultra-High-Cost Precision Drugs
• High-Cost Specialty Drugs
• Mid-Cost Chronic Care Drugs
• Low-Cost High-Volume Drugs

By Service Model
• On-Site Treatment
• Off-Site Treatment
• Third-Party Waste Management Services
• Integrated Digital Waste Monitoring Services

By Service Types
• Disposal
• Recycling
• Collection
• Transportation & Storage
• Others

By Technology Adoption Level
• Manual Waste Tracking
• Barcode-Based Systems
• RFID-Based Systems
• AI-Enabled Predictive Systems
• Fully Integrated Smart Hospital Systems

Key Players
• Stericycle, Inc.
• Veolia
• Waste Management, Inc.
• CLEAN HARBORS, INC.
• REMONDIS SE & Co. KG
• Republic Services
• BioMedical Waste Solutions, LLC
• NIPON MEDICAL WASTE MANAGEMENT
• KANSAI TSUSHYOU CO., LTD.
• Daniels Sharpsmart Inc.

Major Highlights
This report delivers a comprehensive overview of the Japan Hospital Drug Waste Management Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Japan Hospital Drug Waste Management Market. The Japan Hospital Drug Waste Management Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
South America (Colombia, Brazil, Argentina, Rest of South America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification
Increase Your Customer Base by 3X using our Partner Identification tool
Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

181 Pages
1. Definition and Overview
1.1. Study Objectives
1.2. Market Definition
1.3. Market Scope
1.4. Stakeholder Analysis
1.5. Currency Considered
1.6. Study Period
2. Executive Summary
2.1. Key Takeaways
2.2. Top To Bottom Analysis
2.3. Market Share Analysis
2.4. Data Points from Key Primary Interviews
2.5. Data Points from Key Secondary Databases
2.6. Market Snapshot
2.7. Geographical Snapshot
3. Dynamics
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Cost of Specialty & Biologic Drugs
3.1.1.2. Strict Regulatory & Environmental Compliance
3.1.1.3. Aging Population & Growing Drug Utilization
3.1.2. Restraints
3.1.2.1. High Initial Investment Costs
3.1.2.2. Integration & Operational Complexity
3.1.3. Opportunity
3.1.3.1. AI & Predictive Inventory Management
3.1.3.2. Smart Cold-Chain Monitoring for Biologics
3.1.3.3. ESG & Carbon Management Initiatives
3.1.4. Trends
3.1.4.1. Digitalization of Hospital Pharmacy Operations
3.1.4.2. Shift Toward Centralized & Shared Drug Optimization Programs s
3.1.5. Impact Analysis
4. Industry Analysis
4.1. Porter’s Five Force Analysis – Japan Hospital Drug Waste Management Market
4.2. Geopolitical & Supply Chain Exposure
4.3. Social & Patient-Centric Factors
4.4. Economic Factors
4.5. Pricing Analysis
4.6. Regulatory Analysis
4.7. Go-To-Market (GTM) Strategy
4.8. Innovation & R&D Trends
4.9. Sustainability and ESG Analysis
4.10. Hospital Drug Waste Management Market Participants
4.11. Buyer Decision Criteria & Adoption Drivers
4.12. DMI Opinion – Strategic Outlook for the Japan Hospital Drug Waste Management Market
5. By Type of Waste
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Waste
5.1.2. Market Attractiveness Index, By Type of Waste
5.2. General Medical Waste*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Infectious Medical Waste
5.4. Hazardous Medical Waste
5.5. Radioactive Medical Waste
5.6. Controlled Substance Waste
5.7. Expired Pharmaceutical Waste
5.8. Others
6. By Treatment Method
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Method
6.1.2. Market Attractiveness Index, By Treatment Method
6.2. Incineration*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Autoclaving
6.4. Chemical Treatment
6.5. Microwave Treatment
6.6. Encapsulation
6.7. Others
7. By Waste Source Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Waste Source Type
7.1.2. Market Attractiveness Index, By Waste Source Type
7.2. Expired Inventory Waste*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Partially Used Drug Waste
7.4. Prescription Change Waste
7.5. Cold-Chain Spoilage Waste
7.6. Packaging & Handling Waste
7.7. Compounding & Preparation Waste
7.8. Others
8. By Drug Value Category
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Value Category
8.1.2. Market Attractiveness Index, By Drug Value Category
8.2. Ultra-High-Cost Precision Drugs*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. High-Cost Specialty Drugs
8.4. Mid-Cost Chronic Care Drugs
8.5. Low-Cost High-Volume Drugs
9. By Service Model
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Model
9.1.2. Market Attractiveness Index, By Service Model
9.2. On-Site Treatment*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Off-Site Treatment
9.4. Third-Party Waste Management Services
9.5. Integrated Digital Waste Monitoring Services
10. By Service Types
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Types
10.1.2. Market Attractiveness Index, By Service Types
10.2. Disposal*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Recycling
10.4. Collection
10.5. Transportation & Storage
10.6. Others
11. By Technology Adoption Level
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology Adoption Level
11.1.2. Market Attractiveness Index, By Technology Adoption Level
11.2. Manual Waste Tracking*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Barcode-Based Systems
11.4. RFID-Based Systems
11.5. AI-Enabled Predictive Systems
11.6. Fully Integrated Smart Hospital Systems
12. Competitive Landscape Analysis
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
12.4. Partner Identification Analysis
12.5. Investment & Funding Landscape
12.6. Strategic Alliances & Innovation Pipelines
13. Company Profiles
13.1. Stericycle, Inc.*
13.1.1. Company Overview
13.1.2. Product Portfolio
13.1.3. Revenue Analysis
13.1.4. Pricing Analysis
13.1.5. SWOT Analysis
13.1.6. Recent Developments
13.1.6.1. Major Deals
13.1.6.2. M&A
13.1.6.3. Collaboration
13.1.6.4. Acquisition
13.1.6.5. Joint Ventures
13.1.6.6. Innovations
13.1.7. Recent News
13.1.7.1. Events
13.1.7.2. Conferences
13.1.7.3. Symposiums
13.1.7.4. Webinars
13.2. Veolia
13.3. Waste Management, Inc.
13.4. CLEAN HARBORS, INC.
13.5. REMONDIS SE & Co. KG
13.6. Republic Services
13.7. BioMedical Waste Solutions, LLC
13.8. NIPON MEDICAL WASTE MANAGEMENT
13.9. KANSAI TSUSHYOU CO., LTD.
13.10. Daniels Sharpsmart Inc. (LIST NOT EXHAUSTIVE)
14. Japan Hospital Drug Waste Management Market – Research Methodology
14.1. Research Data
14.1.1. Secondary Data
14.1.2. Primary Data
14.1.3. CAGR Analysis
14.2. Market Size Estimation Methodology
14.2.1. Bottom-Up Approach
14.2.2. Top-Down Approach
14.3. Market Breakdown & Data Triangulation
14.4. Research Assumptions
14.5. Limitations
15. Appendix
15.1. About Us and Services
15.2. Contact Us
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.